301 related articles for article (PubMed ID: 30797890)
1. Predictors of Radiation-Induced Liver Disease in Eastern and Western Patients With Hepatocellular Carcinoma Undergoing Proton Beam Therapy.
Hsieh CE; Venkatesulu BP; Lee CH; Hung SP; Wong PF; Aithala SP; Kim BK; Rao A; Tung-Chieh Chang J; Tsang NM; Wang CC; Lee CC; Lin CC; Tseng JH; Chou WC; Wang YC; Krishnan S; Hong JH
Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):73-86. PubMed ID: 30797890
[TBL] [Abstract][Full Text] [Related]
2. Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication.
Cheng JC; Wu JK; Huang CM; Liu HS; Huang DY; Cheng SH; Tsai SY; Jian JJ; Lin YM; Cheng TI; Horng CF; Huang AT
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):156-62. PubMed ID: 12182986
[TBL] [Abstract][Full Text] [Related]
3. Radiation-induced liver disease after stereotactic body radiotherapy for small hepatocellular carcinoma: clinical and dose-volumetric parameters.
Jung J; Yoon SM; Kim SY; Cho B; Park JH; Kim SS; Song SY; Lee SW; Ahn SD; Choi EK; Kim JH
Radiat Oncol; 2013 Oct; 8():249. PubMed ID: 24160910
[TBL] [Abstract][Full Text] [Related]
4. Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease.
Cheng JC; Wu JK; Lee PC; Liu HS; Jian JJ; Lin YM; Sung JL; Jan GJ
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1502-9. PubMed ID: 15590181
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric analysis and comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy for patients with hepatocellular carcinoma and radiation-induced liver disease.
Cheng JC; Wu JK; Huang CM; Liu HS; Huang DY; Tsai SY; Cheng SH; Jian JJ; Huang AT
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):229-34. PubMed ID: 12694843
[TBL] [Abstract][Full Text] [Related]
6. Analysis of repeated proton beam therapy for patients with hepatocellular carcinoma.
Oshiro Y; Mizumoto M; Okumura T; Fukuda K; Fukumitsu N; Abei M; Ishikawa H; Takizawa D; Sakurai H
Radiother Oncol; 2017 May; 123(2):240-245. PubMed ID: 28366501
[TBL] [Abstract][Full Text] [Related]
7. Prognostic analysis of radiation-induced liver damage following carbon-ion radiotherapy for hepatocellular carcinoma.
Hayashi K; Suzuki O; Wakisaka Y; Ichise K; Uchida H; Anzai M; Hasegawa A; Seo Y; Shimizu S; Ishii T; Teshima T; Fujimoto J; Ogawa K
Radiat Oncol; 2024 Apr; 19(1):51. PubMed ID: 38649902
[TBL] [Abstract][Full Text] [Related]
8. Capacity of proton beams in preserving normal liver tissue during proton beam therapy for hepatocellular carcinoma.
Tsai YL; Takei H; Iizumi T; Okumura T; Sekino Y; Numajiri H; Ishikawa H; Sakae T; Sakurai H
J Radiat Res; 2021 Jan; 62(1):133-141. PubMed ID: 33392617
[TBL] [Abstract][Full Text] [Related]
9. How small is TOO small? New liver constraint is needed- Proton therapy of hepatocellular carcinoma patients with small normal liver.
Lee CH; Hung SP; Hong JH; Chang JT; Tsang NM; Chan KM; Tseng JH; Huang SC; Lin SM; Lien JM; Liu NJ; Lin CC; Chen WT; Chen WY; Chen PJ; Huang BS
PLoS One; 2018; 13(9):e0203854. PubMed ID: 30204800
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of radiation-induced liver disease after stereotactic body radiation therapy for hepatocellular carcinoma.
Jun BG; Kim YD; Cheon GJ; Kim ES; Jwa E; Kim SG; Kim YS; Kim BS; Jeong SW; Jang JY; Lee SH; Kim HS
Korean J Intern Med; 2018 Nov; 33(6):1093-1102. PubMed ID: 28844122
[TBL] [Abstract][Full Text] [Related]
11. Functional Liver Imaging and Dosimetry to Predict Hepatotoxicity Risk in Cirrhotic Patients With Primary Liver Cancer.
Schaub SK; Apisarnthanarax S; Price RG; Nyflot MJ; Chapman TR; Matesan M; Vesselle HJ; Bowen SR
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1339-1348. PubMed ID: 30170100
[TBL] [Abstract][Full Text] [Related]
12. Clinical parameters for predicting radiation-induced liver disease after intrahepatic reirradiation for hepatocellular carcinoma.
Huang Y; Chen SW; Fan CC; Ting LL; Kuo CC; Chiou JF
Radiat Oncol; 2016 Jul; 11(1):89. PubMed ID: 27369241
[TBL] [Abstract][Full Text] [Related]
13. Association between pretreatment retention rate of indocyanine green 15 min after administration and life prognosis in patients with HCC treated by proton beam therapy.
Mizumoto M; Oshiro Y; Okumura T; Fukuda K; Fukumitsu N; Abei M; Ishikawa H; Ohnishi K; Numajiri H; Tsuboi K; Sakurai H
Radiother Oncol; 2014 Oct; 113(1):54-9. PubMed ID: 25248924
[TBL] [Abstract][Full Text] [Related]
14. Investigation of dosimetric variations of liver radiotherapy using deformable registration of planning CT and cone-beam CT.
Huang P; Yu G; Chen J; Ma C; Qin S; Yin Y; Liang Y; Li H; Li D
J Appl Clin Med Phys; 2017 Jan; 18(1):66-75. PubMed ID: 28291931
[TBL] [Abstract][Full Text] [Related]
15. Metabolic liver function after stereotactic body radiation therapy for hepatocellular carcinoma.
Dreher C; Høyer KI; Fode MM; Habermehl D; Combs SE; Høyer M
Acta Oncol; 2016 Jul; 55(7):886-91. PubMed ID: 26878669
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of liver function after proton beam therapy for hepatocellular carcinoma.
Mizumoto M; Okumura T; Hashimoto T; Fukuda K; Oshiro Y; Fukumitsu N; Abei M; Kawaguchi A; Hayashi Y; Ohkawa A; Hashii H; Kanemoto A; Moritake T; Tohno E; Tsuboi K; Sakae T; Sakurai H
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e529-35. PubMed ID: 22284041
[TBL] [Abstract][Full Text] [Related]
17. Treatment Outcome after Fractionated Conformal Radiotherapy for Hepatocellular Carcinoma in Patients with Child-Pugh Classification B in Korea (KROG 16-05).
Bae SH; Park HC; Yoon WS; Yoon SM; Jung IH; Lee IJ; Kim JW; Seong J; Kim TH; Nam TK; Choi Y; Lee SY; Jang HS; Lee DS; Kim JH
Cancer Res Treat; 2019 Oct; 51(4):1589-1599. PubMed ID: 30971065
[TBL] [Abstract][Full Text] [Related]
18. Early radiation-induced liver toxicities are associated with poor survival in patients with advanced hepatocellular carcinoma.
Lai YL; Kuo YC; Lai HC; Peng CY; Wang YC; Liang JA; Chen SW
Asia Pac J Clin Oncol; 2016 Dec; 12(4):437-443. PubMed ID: 26947774
[TBL] [Abstract][Full Text] [Related]
19. Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma.
Xu ZY; Liang SX; Zhu J; Zhu XD; Zhao JD; Lu HJ; Yang YL; Chen L; Wang AY; Fu XL; Jiang GL
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):189-95. PubMed ID: 16542787
[TBL] [Abstract][Full Text] [Related]
20. Proton Beam Therapy in Liver Malignancies.
Siddiqui O; Pollock A; Samanta S; Kaiser A; Molitoris JK
Curr Oncol Rep; 2020 Feb; 22(3):30. PubMed ID: 32108284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
